Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

SeaDragon announces new Squalene sales contract

SeaDragon announces new Squalene sales contract

Australasia’s largest refiner and blender of fish oils, SeaDragon (NZX:SEA), has announced that it has signed a new squalene sales agreement that will underpin its financial performance for the current financial year and into 2016.

Following on from its March announcement of a major new raw material supply contract for its existing plant, SeaDragon has signed a sales contract to take the refined squalene to customers throughout Australasia.

The contract covers finished product using a significant amount of the raw material obtained from the supply agreement. The names of the party and the terms of the contract are confidential.

SeaDragon Chief Executive Ross Keeley said: “This contract represents a significant win for SeaDragon and vindicates our decision to take bold steps to secure raw material for our squalene processing factory.

“We are now very well positioned for the current financial year and beyond and are looking forward to 2015 when the completion of our new oil refinery plant in Nelson will allow a major expansion in our range of Omega-3 fish oil products.”

About SeaDragon www.seadragon.co.nz
SeaDragon (NZX:SEA) is Australasia’s largest refiner and blender of high-quality, internationally certified concentrated fish oils and fractions, including Omega-3 oils. Our oils are sourced from fish caught in the clean and pure waters around New Zealand, in the Southern Ocean, and elsewhere. We have more than 20 years’ experience processing fish oils and we are recognised for the quality and purity of our products. We supply health supplement manufacturers around the world to meet the burgeoning demand for pure, high-quality fish oils, which are scientifically proven to deliver significant human health benefits such as lowering the risk of heart disease, improving brain function and joint health. The majority of our supply is exported.

ENDS

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Business Headlines | Sci-Tech Headlines

 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.